share_log

Novo Integrated Sciences | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Novo Integrated Sciences | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Novo Integrated Sciences | NT 10-Q:季报延迟披露公告
美股sec公告 ·  07/15 16:20
Moomoo AI 已提取核心信息
Novo Integrated Sciences, Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the quarter ended May 31, 2024. The company cited the need for additional time to obtain and compile certain required information as the reason for the delay, stating that it could not be resolved without unreasonable effort and expense. Novo Integrated Sciences expects to file the report within the five-day extension period allowed by the SEC. The company confirmed that all other periodic reports have been filed as required, and there are no significant changes in results of operations from the corresponding period for the last fiscal year anticipated in the earnings statements to be included in the delayed report. The notification was signed by CEO Robert Mattacchione on July 15, 2024.
Novo Integrated Sciences, Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the quarter ended May 31, 2024. The company cited the need for additional time to obtain and compile certain required information as the reason for the delay, stating that it could not be resolved without unreasonable effort and expense. Novo Integrated Sciences expects to file the report within the five-day extension period allowed by the SEC. The company confirmed that all other periodic reports have been filed as required, and there are no significant changes in results of operations from the corresponding period for the last fiscal year anticipated in the earnings statements to be included in the delayed report. The notification was signed by CEO Robert Mattacchione on July 15, 2024.
Novo Integrated Sciences公司宣布延迟提交2024年5月31日结束的第10-Q表格的季度报告。公司称需要额外的时间来获取和编译某些必需的信息,这是延迟报告的原因,并称该问题无法在没有不合理的努力和费用的情况下解决。Novo Integrated Sciences预计在美国证券交易委员会允许的五天延期期间内提交报告。该公司确认所有其他周期性报告已按要求提交,并且预计在延迟报告中包括的盈利报告中,营运结果与去年相应时期无显著变化。该通知由首席执行官罗伯特·马塔基昂(Robert Mattacchione)于2024年7月15日签署。
Novo Integrated Sciences公司宣布延迟提交2024年5月31日结束的第10-Q表格的季度报告。公司称需要额外的时间来获取和编译某些必需的信息,这是延迟报告的原因,并称该问题无法在没有不合理的努力和费用的情况下解决。Novo Integrated Sciences预计在美国证券交易委员会允许的五天延期期间内提交报告。该公司确认所有其他周期性报告已按要求提交,并且预计在延迟报告中包括的盈利报告中,营运结果与去年相应时期无显著变化。该通知由首席执行官罗伯特·马塔基昂(Robert Mattacchione)于2024年7月15日签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息